Levo-Stepholidine As a Potential Cognitive Enhancer: Insights into Executive Function and Memory Improvements

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2025 Jan 8

PMID 39767588

Authors

Zhengwei Hu

Xueqing Zhu

Yirui Liang

Yuqiu Zhang

Ping Zheng

Xuehan Zhang

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Levo-Stepholidine (-SPD), a compound extracted from Chinese herbs, has the potential to treat psychotic disorders where cognitive deficits are a critical challenge. -SPD displays a D1R agonism/D2R antagonism pharmacological profile, and its effect on cognitive function is still vague and lacks comprehensive study. Here, we investigated the impact of l-SPD on two core indexes of executive function, working memory and response inhibition, and learning and memory.

Methods: Using a delayed alternation T-maze task (DAT), we investigated the impact of -SPD on working memory, evaluated its effect on response inhibition using the stop-signal task (SST), and assessed the impact on learning and memory using trace fear conditioning in Sprague-Dawley rats. We further evaluated its effects on prefrontal glutamate receptor expression using western blot.

Results: Rats receiving -SPD made fewer errors in the T-maze, exhibited faster stop action in response to the stop signal, and showed longer-lasting memory retention. Molecular mechanism investigations reveal that -SPD upregulates the expression of prefrontal glutamate receptors. These results demonstrate that -SPD improves executive function and memory.

Conclusions: Here, we show the enhancement effect of l-SPD on cognitive function, which provides essential implicants for the treatment of cognitive deficits, which is a critical unmet need in psychiatric care.

References

Hao J, Sun N, Lei L, Li X, Yao B, Sun K . L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor/PKA signaling pathway. Cell Death Dis. 2015; 6:e1965. PMC: 4670924. DOI: 10.1038/cddis.2015.315. View

Forbes N, Carrick L, McIntosh A, Lawrie S . Working memory in schizophrenia: a meta-analysis. Psychol Med. 2008; 39(6):889-905. DOI: 10.1017/S0033291708004558. View

Jin G, Zhu Z, Fu Y . (-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci. 2002; 23(1):4-7. DOI: 10.1016/s0165-6147(00)01929-5. View

Yue K, Ma B, Chen L, Tian X, Ru Q, Gan Y . L-Stepholidine, a naturally occurring dopamine D1 receptor agonist and D2 receptor antagonist, attenuates heroin self-administration and cue-induced reinstatement in rats. Neuroreport. 2013; 25(1):7-11. DOI: 10.1097/WNR.0000000000000012. View

Yang Y, Lee S, Imamura F, Gowda K, Amin S, Mailman R . D1 dopamine receptors intrinsic activity and functional selectivity affect working memory in prefrontal cortex. Mol Psychiatry. 2018; 26(2):645-655. PMC: 9710464. DOI: 10.1038/s41380-018-0312-1. View

Dias R, Robbins T, Roberts A . Dissociable forms of inhibitory control within prefrontal cortex with an analog of the Wisconsin Card Sort Test: restriction to novel situations and independence from "on-line" processing. J Neurosci. 1997; 17(23):9285-97. PMC: 6573594. View

Williams S, Goldman-Rakic P . Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex. 1998; 8(4):321-45. DOI: 10.1093/cercor/8.4.321. View

Cimino J, Zhou M, Waxmonsky J, Mailman R, Yang Y . Characterization of behavioral changes in T-maze alternation from dopamine D agonists with different receptor coupling mechanisms. Psychopharmacology (Berl). 2023; 240(10):2187-2199. PMC: 10693963. DOI: 10.1007/s00213-023-06440-5. View

Ho C, Chen H, Chiu N, Shen E, Lue H . Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder. J Formos Med Assoc. 2009; 108(10):788-93. DOI: 10.1016/S0929-6646(09)60406-X. View

10.

Abi-Dargham A . Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol. 2004; 7 Suppl 1:S1-5. DOI: 10.1017/S1461145704004110. View

11.

Natesan S, Reckless G, Barlow K, Odontiadis J, Nobrega J, Baker G . The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology (Berl). 2008; 199(2):275-89. DOI: 10.1007/s00213-008-1172-1. View

12.

Sabe M, Pillinger T, Kaiser S, Chen C, Taipale H, Tanskanen A . Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev. 2022; 136:104608. DOI: 10.1016/j.neubiorev.2022.104608. View

13.

Ellenbroek B, Zhang X, Jin G . Effects of (-)stepholidine in animal models for schizophrenia. Acta Pharmacol Sin. 2006; 27(9):1111-8. DOI: 10.1111/j.1745-7254.2006.00365.x. View

14.

Zhang B, Guo F, Ma Y, Song Y, Lin R, Shen F . Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD. Sci Rep. 2017; 7(1):3809. PMC: 5476681. DOI: 10.1038/s41598-017-03680-2. View

15.

Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y . Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci. 2002; 22(9):3708-19. PMC: 6758376. DOI: 20026302. View

16.

Reneaux M, Gupta R . Prefronto-cortical dopamine D1 receptor sensitivity can critically influence working memory maintenance during delayed response tasks. PLoS One. 2018; 13(5):e0198136. PMC: 5973564. DOI: 10.1371/journal.pone.0198136. View

17.

Diamond A . Executive functions. Annu Rev Psychol. 2012; 64:135-68. PMC: 4084861. DOI: 10.1146/annurev-psych-113011-143750. View

18.

Bari A, Robbins T . Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol. 2013; 108:44-79. DOI: 10.1016/j.pneurobio.2013.06.005. View

19.

Sakurai H, Bies R, Stroup S, Keefe R, Rajji T, Suzuki T . Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. Schizophr Bull. 2012; 39(3):564-74. PMC: 3627781. DOI: 10.1093/schbul/sbr189. View

20.

Gray B, Hahn B, Robinson B, Harvey A, Leonard C, Luck S . Relationships between divided attention and working memory impairment in people with schizophrenia. Schizophr Bull. 2014; 40(6):1462-71. PMC: 4193709. DOI: 10.1093/schbul/sbu015. View